ArticleBlood advances2023

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence.

Rory M Shallis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.